Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy

Urabe Fumihiko; Ochiya Takahiro; Egawa Shin

首页> 外文期刊>European urology >Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy

【24h】

Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy

机译：Re：验证新型尿液外科基因表达测定的前瞻性自适应实用试验，以预测前列腺特异性抗原2-10ng / ml在初始活组织检查患者中预测高级前列腺癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第2期|共3页
作者
Urabe Fumihiko; Ochiya Takahiro; Egawa Shin;
展开▼
作者单位

Natl Canc Ctr Div Mol &

Cellular Med Res Inst Tokyo Japan;

Natl Canc Ctr Div Mol &

Cellular Med Res Inst Tokyo Japan;

Jikei Univ Dept Urol Sch Med Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献

1. Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy [J] . Urabe Fumihiko, Ochiya Takahiro, Egawa Shin European urology . 2019,第2期

机译：Re：验证新型尿液外科基因表达测定的前瞻性自适应实用试验，以预测前列腺特异性抗原2-10ng / ml在初始活组织检查患者中预测高级前列腺癌
2. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10ng/ml at Initial Biopsy [J] . James McKiernan, Michael J. Donovan, Eric Margolis, European urology . 2018,第6期

机译：一种潜在的自适应效用试验，用于验证新型尿液外部基因表达测定的性能，以在初始活组织检查下预测前列腺特异性抗原2-10ng / ml患者的高级前列腺癌
3. Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels <= 10 ng/ml at initial biopsy [J] . Lin Chia-Yen, Wang Shian-Shiang, Yang Cheng-Kuang, Urologic oncology . 2019,第11期

机译：遗传多态性和碳酸酐酶9表达可以预测前列腺特异性抗原水平<= 10ng / ml在初始活组织检查的患者中的节点转移前列腺癌风险
4. A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2–10 ng/mL at initial biopsy [O] . Ya-Di He, Wen Tao, Tao He, 2021

机译：一种尿细胞外囊泡CircrCRNA分类器用于检测初始活组织检查的前列腺特异性抗原2-10ng / ml患者的高级前列腺癌
5. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy [O] . James McKiernan, Michael J. Donovan, Eric Margolis, 2018

机译：一种预期的自适应效用试验，用于验证新型尿液外部基因表达测定的性能，以预测前列腺特异性抗原2-10ng / ml在初始活组织检查中的高档前列腺癌

Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10 ng/ml at Initial Biopsy

著录项

相似文献

相关主题

期刊订阅